title: Two-stage radical gastrectomy for perforated gastric cancer.
abstract: BACKGROUND
  Perforation represents a severe complication of gastric cancer. Because it is rare, only few data are available regarding treatment and prognosis.
  
  
  METHODS
  Patients with perforated gastric cancer were identified from two prospective registers of gastric cancer and of gastroduodenal ulcer.
  
  
  RESULTS
  Between February 1982 and June 1999 23 patients with perforated gastric cancer were treated surgically. This corresponds to only 1.8% of 1273 patients presenting with gastric cancer, but to 14% of 161 patients presenting with gastric perforation during this time period. Overall, post-operative mortality was 13% (3/23). Initially, 21 patients had palliative operations. Two patients had a potentially curative procedure at the emergency operation and one of the two died post-operatively. Another six patients had potentially curative gastrectomy at a second stage and no patient died post-operatively. The 5-year overall survival was estimated at 50% for all eight curatively-treated patients. Median survival of palliatively treated patients was 6 months.
  
  
  CONCLUSIONS
  Perforation of the stomach should raise suspicion of malignancy, particularly in elderly patients. At the time of perforation radical gastrectomy with lymphadenectomy is mostly not advised, either because a diagnosis of gastric cancer is not confirmed or because the patient's condition does not allow extended surgery. In this situation it is suggested to consider a two-stage procedure and direct the primary operation at the treatment of perforation and peritonitis. Tumour staging can be completed when the patient has recovered and a radical operation with curative intent can be planned without compromising long-term prognosis. Our observations and a review of the literature confirm that perforation of gastric cancer does not preclude long-term survival per se in a substantial number of patients.
authors.affiliation: Section of Surgical Oncology, University of Heidelberg, Heidelberg, Germany. thomas_lehnert@med.uni-heidelberg.de
authors.forename: T
authors.initials: T
authors.lastname: Lehnert
authors.forename: K
authors.initials: K
authors.lastname: Buhl
authors.forename: M
authors.initials: M
authors.lastname: Dueck
authors.forename: U
authors.initials: U
authors.lastname: Hinz
authors.forename: C
authors.initials: C
authors.lastname: Herfarth
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005743:Gastrectomy / Q000379:methods*; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D010166:Palliative Care; D011184:Postoperative Period; D011379:Prognosis; D011446:Prospective Studies; D012086:Reoperation; D013274:Stomach Neoplasms / Q000150:complications / Q000401:mortality / Q000601:surgery*; D016019:Survival Analysis